KUTOK JEFFERY (Chief Scientific Officer) received a stock award from INFINITY PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/13/2020ACC: 0000899243-20-001081
Officer· Chief Scientific Officer
Since Aug 2018
+514.22K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
514.22K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+64.22K
Price / share
—
Trade value
—
% of position
488.1%
1/10/2020
13.16K→77.38K
Total
Net shares
+64.22K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2020 | A · Award | +64.22K | — | — | 488.1% | 13.16K | 77.38K |
| Total | +64.22K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
450K shares
Shares
+450K
Strike price
1.25
Held after
450K
Exercisable
—
1/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock450K shares | 1/10/2020 | A · Award | +450K | 1.25 | — | 450K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10.74K
Total
10.74K indirect10.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.74K | Indirect |
| Total | 10.74K | 10.74K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported